Capital International Investors
ASND icon

Capital International Investors’s Ascendis Pharma A/S ASND Stock Holding History

Capital International Investors’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530M Buy
1,988,614
+29,771
+2% +$6.95M 0.11% 140
2026
Q1 		$448M Sell
1,958,843
-1,105,100
-36% -$248M 0.11% 158
2025
Q4 		$653M Buy
3,063,943
+3,327
+0.1% +$687K 0.1% 152
2025
Q3 		$608M Buy
3,060,616
+13,685
+0.4% +$2.55M 0.1% 154
2025
Q2 		$526M Buy
3,046,931
+172,139
+6% +$28M 0.09% 161
2025
Q1 		$448M Buy
2,874,792
+11,543
+0.4% +$1.65M 0.09% 167
2024
Q4 		$394M Buy
2,863,249
+753,859
+36% +$99.1M 0.07% 177
2024
Q3 		$315M Buy
2,109,390
+5,092
+0.2% +$688K 0.06% 195
2024
Q2 		$287M Sell
2,104,298
-87,014
-4% -$11.8M 0.06% 193
2024
Q1 		$331M Buy
2,191,312
+10,044
+0.5% +$1.43M 0.07% 197
2023
Q4 		$275M Buy
2,181,268
+12,825
+0.6% +$1.28M 0.06% 201
2023
Q3 		$203M Buy
2,168,443
+173,172
+9% +$16.2M 0.05% 215
2023
Q2 		$178M Buy
1,995,271
+6,165
+0.3% +$537K 0.04% 243
2023
Q1 		$213M Buy
1,989,106
+421,109
+27% +$48.2M 0.05% 225
2022
Q4 		$191M Buy
1,567,997
+248,546
+19% +$28.9M 0.05% 244
2022
Q3 		$136M Buy
1,319,451
+12,430
+1% +$1.18M 0.04% 266
2022
Q2 		$122M Buy
1,307,021
+1,060,819
+431% +$100M 0.03% 283
2022
Q1 		$28.9M Buy
+246,202
New +$28.5M 0.01% 386

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors's ASND Position: Q2 2026 in Review

Capital International Investors increased its Ascendis Pharma A/S (ASND) stake by 1.5% in Q2 2026, buying an estimated $6.95M and bringing the position to 1,988,614 shares worth $530M. The position accounts for 0.11% of the portfolio, ranked #140.

Capital International Investors first reported a position in ASND in Q1 2022 and has held it in 18 quarters since. The position peaked at $653M in Q4 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Capital International Investors held 1,988,614 shares of Ascendis Pharma A/S worth $530M as of Q2 2026.
  • Capital International Investors bought 29,771 Ascendis Pharma A/S shares in Q2 2026, an estimated $6.95M.
  • Ascendis Pharma A/S made up 0.11% of Capital International Investors's portfolio in Q2 2026, its #140 holding.
  • Capital International Investors first reported a position in Ascendis Pharma A/S in Q1 2022 and has held it in 18 quarters since.
  • Capital International Investors's Ascendis Pharma A/S position peaked at $653M in Q4 2025.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.